[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.0.26. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
October 25, 1995

On Federal Regulation of Methadone Treatment

Author Affiliations

From The Rockefeller University, New York, NY.

JAMA. 1995;274(16):1307. doi:10.1001/jama.1995.03530160059035
Abstract

A RECENT report from the Institute of Medicine (an affiliate of the National Academy of Sciences) provides an authoritative review of the history and consequences of federal regulation of methadone treatment.1 It examines the assumptions that justified imposition of special restrictions on prescription of methadone and the effects of enforced guidelines on the function of treatment programs.

Since the Narcotic Addict Treatment Act (1974) authorized an unprecedented restriction of the right of physicians to prescribe an approved drug, the experience of the past 20 years can be seen as a major experiment in governmental regulation of medical practice. Given the controversial nature of the subject, both the government and the medical profession in general are fortunate to have had the results of this experiment evaluated at the highest scientific level. Quite properly, I was not included in the deliberations for the Institute of Medicine report. My views on the

First Page Preview View Large
First page PDF preview
First page PDF preview
×